Anika Therapeutics | 应收帐款人





应收帐款人 更改 日
Abbott USD 10.4B 166M 2025-09
Agenus USD 354K 53K 2025-03
Agios Pharmaceuticals USD 5.03M 43K 2025-09
Anika Therapeutics USD 21.99M 1.61M 2025-03
Arrowhead Research USD 218.87M 212.05M 2025-12
Enanta Pharmaceuticals USD 40.16M 1.52M 2024-12
Halozyme Therapeutics USD 346.04M 29.7M 2025-09
Heron Therapeutics USD 67.04M 6.9M 2024-09
Insmed USD 65.26M 10.23M 2025-09
Integra LifeSciences USD 262.16M 22.35M 2025-09
Intrexon USD 1.02M 559K 2024-06
J&J USD 17.61B 235M 2025-09
Karyopharm Therapeutics USD 31.78M 6.82M 2024-09
Ligand Pharmaceuticals USD 58.1M 15.98M 2025-09
MacroGenics USD 69.23M 56.7M 2025-09
Merit Medical Systems USD 231.51M 7.27M 2025-09
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 397M 100M 2025-12
Smith & Nephew USD 1.48B 85M 2025-12
Stryker USD 4.04B 396M 2025-12
Surmodics USD 23.27M 790K 2024-09
Veracyte USD 47.83M 2.99M 2025-09
Xencor USD 21.8M 25.75M 2025-09
Zimmer Biomet Holdings USD 1.7B 106.1M 2025-12


Anika Therapeutics 应收帐款人 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.